IngredientsCetyl laurate is an ester formed by the condensation of cetyl alcohol (1-hexadecanol) and lauric acid (dodecanoic acid). Cetyl laurate is an ester of cetyl alcohol and lauric acid. Its systematic IUPAC name is hexadecyl dodecanoate. It is also recorded under the name palmityl laurate. Additional synonyms in the technical and regulatory literature include dodecanoic acid hexadecyl ester and hexadecyl laurate.
The compound is registered with the following standard identifiers: CAS number 20834-06-4 and EC number 244-071-8. Its chemical formula is C₂₈H₅₆O₂. In the international cosmetic ingredient nomenclature, it is listed as CETYL LAURATE under the INCI (International Nomenclature of Cosmetic Ingredients) system. The EINECS/ELINCS number assigned to cetyl laurate is 244-071-8.
Cetyl laurate belongs to the class of long-chain wax esters — molecules in which a fatty acid is linked through an ester bond to a fatty alcohol. This ingredient contains cetyl alcohol (1-hexadecanol) as the alcoholic component; laurates are salts or esters of lauric acid (dodecanoic acid). The cetyl (hexadecyl) portion contributes a 16-carbon saturated alkyl chain, while the laurate (dodecanoyl) portion contributes a 12-carbon saturated acyl chain, resulting in a combined structure with 28 carbon atoms in the backbone. The molecule is entirely saturated — no carbon-carbon double bonds are present — which gives it the chemical stability, waxy texture, and elevated melting point characteristic of the long-chain cetyl ester family.
Cetyl laurate is a solid wax at room temperature. It is lipophilic and insoluble in water, but soluble in oils and organic solvents. Its physical character — smooth, waxy, odourless, and stable — places it in the same family of materials as the natural spermaceti waxes it is designed to replicate.
Cetyl laurate is not found as a major isolated compound in a single plant or animal source. Rather, it is one of several structurally related cetyl esters that collectively occur in natural wax mixtures. The four esters — cetyl laurate, myristate, palmitate, and stearate — are the main components of spermaceti, a mixture of waxes formerly extracted from the head of the sperm whales, very appreciated in cosmetic and pharmacy because of its physical properties and emolliency.
The precursor components of cetyl laurate occur widely in nature. Lauric acid is a medium-chain fatty acid found in various natural sources, including coconut oil, palm kernel oil, and breast milk. Cetyl alcohol is a natural ingredient extracted from vegetable, coconut, or palm oil. Today, cetyl laurate is produced commercially either by: (a) conventional chemical esterification of cetyl alcohol with lauric acid, or (b) enzyme-catalysed (lipase) synthesis from these natural building blocks, or (c) fractionation and processing of cetyl-ester-containing waxes. Its permitted origins, according to the CosIng regulatory framework, include plant, synthetic, and animal sources.
Cetyl laurate is commercially available primarily as a purified single ester, and also as a component of Cetyl Esters Wax — a multi-component mixture with pharmacopoeial monograph status. Cetyl Esters Wax is a mixture consisting primarily of esters of saturated fatty alcohols (C12 to C18) and saturated fatty acids (C12 to C20). It meets the monograph of the US Pharmacopeia and can be used in OTC products and topical pharmaceuticals. In finished product formulations, cetyl laurate appears as a wax component incorporated into creams, lotions, hair-care products, and lip products. Applications include OTC preparations, creams, lotions, sunscreens, hair care, and color cosmetics.
Cetyl laurate was not historically isolated as a pure compound; its practical history runs parallel to that of spermaceti, the complex wax mixture of which it is a constituent. Spermaceti is a wax, liquid at body temperature, obtained from the head of a sperm whale or bottlenose whale. Spermaceti wax is extracted from sperm oil by crystallisation at 6 °C, when treated by pressure and a chemical solution of caustic alkali; spermaceti forms brilliant white crystals that are hard but oily to the touch, and are devoid of taste or smell, making it very useful as an ingredient in cosmetics, leatherworking, and lubricants.
Spermaceti was used in medicine in England from the 15th century and later in cosmetics, pharmacy, and also in candles. In medieval and early modern Europe, spermaceti found primary application in medicinal ointments and cosmetic formulations, valued for its smooth texture and stability; it was blended into salves for skin conditions, cold creams, and pomades, often appearing in apothecary recipes by the 15th century in England. Its use extended to perfumes as a fixative base, enhancing the longevity of scents in luxury goods favoured by elites during the 16th century, when whale products became symbols of affluence in courts and among merchants.
Spermaceti was used chiefly in ointments, cosmetic creams, fine wax candles, pomades, and textile finishing; later it was used for industrial lubricants. In the pharmacopoeial tradition, the substance was also used in making candles of a standard photometric value, in the dressing of fabrics, and as a pharmaceutical excipient, especially in cerates and ointments. During the 18th and 19th centuries, the demand for spermaceti reached its peak: over 200,000 sperm whales were killed in the 19th century alone to harvest this waxy substance, and this intensive hunting severely depleted whale populations, prompting international conservation efforts.
Spermaceti consists principally of cetyl palmitate (the ester of cetyl alcohol and palmitic acid), C₁₅H₃₁COOC₁₆H₃₃. Chemically, spermaceti is primarily composed of wax esters, with cetyl palmitate making up about 70% of its composition. Cetyl laurate is a minor but genuine constituent of spermaceti alongside the other cetyl esters (myristate, palmitate, stearate). The level of wax esters in the spermaceti organ increases with the age of the whale: 38–51% in calves, 58–87% in adult females, and 71–94% in adult males.
The whales were saved from extinction with the ban on whale oil use in 1972 followed by the species gaining full protection from whaling in 1986. This regulatory shift drove formulators to develop and adopt synthetic or plant-derived alternatives to spermaceti. USP-grade cetyl esters are employed in niche formulations, including high-end cosmetics like creams and lotions for viscosity enhancement and texture improvement, as well as select veterinary medicines for ointment bases. Regulatory bodies, including the FDA, recognise synthetic cetyl esters as safe for cosmetic and pharmaceutical use under the National Formulary (NF) standards. The plant-derived and enzymatically produced cetyl esters — including cetyl laurate — now function as the sustainable substitutes for the historical spermaceti waxes.
Cetyl laurate is itself the active molecule of interest, rather than an extract containing multiple secondary metabolites. When incorporated into cosmetic, topical pharmaceutical, or supplement preparations, cetyl laurate functions through its specific physicochemical and biochemical properties. Upon hydrolysis — whether enzymatic in the skin, in the gut, or in formulation — cetyl laurate releases its two parent fatty compounds: cetyl alcohol (1-hexadecanol) and lauric acid (dodecanoic acid). The pharmacological and biological properties attributed to cetyl laurate preparations thus reflect a combination of the intact ester's physical action and the potential bioactivity of these hydrolysis products.
Cetyl alcohol is a natural ingredient extracted from vegetable, coconut, or palm oil. As a long-chain fatty alcohol, it is classified as an emollient, occlusive, and emulsion stabiliser. Its 16-carbon chain confers waxy, film-forming properties upon surfaces to which it is applied.
Lauric acid, chemically known as dodecanoic acid, is a saturated fatty acid with a 12-carbon atom chain; it is abundantly present in nature, particularly in coconut oil, where it constitutes nearly 50% of the fatty acid content. Lauric acid possesses well-documented bioactivity as a medium-chain fatty acid (MCFA) and is the dominant fatty acid in the human skin's own antimicrobial arsenal. Lauric acid (C12:0), a minor component of the sebum, is the most potent antimicrobial saturated fatty acid.
The primary established mechanism for cetyl laurate in topical use is emolliency — the physical softening and smoothing of the skin surface. According to INCI function classifications, cetyl laurate functions as an emollient (softens and smoothes the skin), a skin conditioning agent (maintains skin in good condition), and a viscosity controlling agent (increases or decreases the viscosity of cosmetics). Like other long-chain wax esters, cetyl laurate forms a thin, occlusive film over the stratum corneum, which physically retards transepidermal water loss (TEWL) and supports the structural integrity of the skin barrier.
As a fatty acid component, lauric acid (the hydrolysis product) supports lipid balance in the stratum corneum, helping to strengthen the skin barrier and reduce transepidermal water loss (TEWL), which enhances moisture retention and texture.
Upon hydrolysis of cetyl laurate at the skin surface — by endogenous skin esterases, sebaceous lipases, or microbial lipases — free lauric acid is released. Free lauric acid has demonstrated intrinsic antimicrobial activity. The mechanism of action behind lauric acid's antimicrobial activity lies in its ability to disrupt the lipid membranes of microorganisms, leading to leakage of cellular contents and eventual cell death. Lauric acid has a broad spectrum of anti-microbiological activities against enveloped viruses and various bacteria.
Fatty acids represent key antimicrobial components of skin's innate immunity, synthesised in the epidermis or secreted by sebaceous glands; they act as antimicrobial agents and confer protection against pathogens. Various free fatty acids have shown antibacterial activity against a range of Gram-positive bacteria, but not Gram-negative bacteria. It should be noted explicitly that these antimicrobial properties are characterised for free lauric acid; whether cetyl laurate itself (as an intact ester) exerts the same effects on microorganisms, or whether sufficient hydrolysis occurs in real-world topical applications to produce biologically meaningful free lauric acid concentrations, has not been established by dedicated human clinical trials.
Cetyl laurate acts as a wax component that modulates the rheological properties of emulsified systems. NF Cetyl Esters Wax (of which cetyl laurate is a component) is primarily used to thicken emulsions while acting as an emollient for improved feel; it functions as a thickener, emollient, and gellant, and formulators can find stabilising or co-emulsifier abilities depending on the system.
Research has defined the synthetic biochemical mechanism by which cetyl laurate is now produced industrially. A solvent-free biocatalytic process for the synthesis of high quality cetyl laurate, myristate, palmitate, and stearate has been optimised; this enzymatic procedure follows the fundamental principles of Green Chemistry and leads to sustainable products, which can be labelled as natural and conform to the principal requirements for their use in high value-added goods. The biocatalyst used is commercially available immobilised lipase (Novozym® 435, a preparation of Candida antarctica lipase B), which catalyses the direct esterification of cetyl alcohol and lauric acid without solvent. The optimal open-air reactor conditions identified include 60 °C for cetyl laurate synthesis.
A kinetic model for the solvent-free synthesis of cetyl laurate, myristate, palmitate, and stearate using different commercial immobilised lipases has been developed; a pseudo-first-order kinetic model has been proposed and tested to describe the esterification process of the cetyl esters separately and as a mixture similar to natural spermaceti.
Evidence type: Regulatory classification, pharmacopoeial use, and general emollient literature. No dedicated cetyl-laurate-specific clinical trials identified.
Cetyl laurate is officially recognised as an emollient and skin conditioning agent in the EU CosIng ingredient database and in international INCI nomenclature. The broader class of cetyl esters (of which cetyl laurate is a member) carries a pharmacopoeial monograph (USP/NF Cetyl Esters Wax). It meets the monograph of the US Pharmacopeia and can be used in OTC products and topical pharmaceuticals.
The evidence base for emollients as a class is substantial. A number of studies have shown that topical emollients benefit dermatitis; for example, topical emollient alone can improve clinical signs and symptoms of atopic dermatitis. The efficacy of emollient is comparable to that of hydrocortisone for atopic dermatitis in humans, and daily applications of emollient for 6 months can reduce the risk of atopic dermatitis by 50% in infants. However, these findings apply to emollient formulations broadly — no human clinical studies specifically testing cetyl laurate as the isolated active ingredient in skin conditions were identified in the peer-reviewed literature. The evidence for cetyl laurate's specific skin benefit is, therefore, indirect: it rests on its pharmacopoeial classification, its structural membership in a well-characterised class of cosmetic wax esters, and its role as a minor constituent of the historically used spermaceti.
Evidence type: In vitro and animal studies for the laurate moiety; no human clinical trials specific to cetyl laurate itself.
The strongest body of peer-reviewed evidence concerns free lauric acid — the hydrolysis product of cetyl laurate — rather than the ester itself. The strong bactericidal properties of lauric acid (C12:0), a middle chain-free fatty acid, have been shown in a number of studies. A key study evaluated the antimicrobial property of lauric acid against Propionibacterium acnes both in vitro and in vivo. Incubation of the skin bacteria P. acnes, Staphylococcus aureus, and Staphylococcus epidermidis with lauric acid yielded minimal inhibitory concentration (MIC) values against the bacterial growth over 15 times lower than those of benzoyl peroxide (BPO); the lower MIC values of lauric acid indicate stronger antimicrobial properties than that of BPO.
Lauric acid has a broad spectrum of anti-microbiological activities against enveloped viruses and various bacteria, and might be useful to protect against microbial infection and control the balance and distribution of bacteria in human gut microbiota. As promising antibiotic alternatives, fatty acids demonstrate potent activity against multidrug-resistant strains; among tested fatty acids, lauric acid (LA, C12:0) showed strong antimicrobial effects against both S. epidermidis and S. aureus.
Evidence strength assessment: The antimicrobial activity described above is for free lauric acid. No peer-reviewed human clinical trials specifically testing cetyl laurate's antimicrobial function were identified. Whether esterification with cetyl alcohol preserves, abolishes, or modulates the antimicrobial potential of the laurate component — and whether topical application of cetyl laurate delivers meaningful free lauric acid in vivo — remains unstudied in the published clinical literature.
Evidence type: In vitro; mechanistic data for the laurate moiety; no specific human clinical trials for cetyl laurate.
Lauric acid's anti-inflammatory properties play a crucial role in soothing irritated and inflamed skin, making it a valuable ingredient in a wide range of topical formulations; it helps reduce redness, swelling, and discomfort often associated with chronic skin conditions such as psoriasis, eczema, rosacea, and dermatitis. These properties are ascribed to the free fatty acid. For cetyl laurate specifically, no dedicated anti-inflammatory human clinical trials have been published in the peer-reviewed literature.
Evidence type: Pharmacopoeial and formulation science documentation.
The cetyl ester wax class (including cetyl laurate as a component) has established pharmacopoeial standing as a pharmaceutical excipient. NF Cetyl Esters Wax is primarily used to thicken emulsions while acting as an emollient for improved feel, functioning as a thickener, emollient, and gellant. Cetyl esters wax is used in OTC topical preparations including creams, ointments, and pharmaceutical-grade lotions, where it contributes to texture, structural integrity of the emulsion, and skin feel. These USP-grade cetyl esters are employed in niche formulations, including high-end cosmetics like creams and lotions for viscosity enhancement and texture improvement, as well as select veterinary medicines for ointment bases.
Evidence type: Published peer-reviewed process chemistry and biochemical engineering research.
The most specific body of scientific research directly naming cetyl laurate concerns its enzymatic synthesis. Published work from researchers at the University of Murcia (Spain), reported in the journal Bioprocess and Biosystems Engineering (PubMed ID 26801670), describes optimised conditions for solvent-free lipase-catalysed synthesis. The influence of the amount of biocatalyst (Novozym® 435) and the temperature were studied in an open-air batch reactor, before carrying out the synthesis in a high performance vacuum reactor with dry nitrogen input to shift the equilibrium towards product formation. A subsequent kinetic modelling study further characterised the reaction. A kinetic model for the solvent-free synthesis of cetyl laurate, myristate, palmitate, and stearate using different commercial immobilised lipases has been developed; a pseudo-first-order kinetic model has been proposed and tested to describe the esterification process of the cetyl esters separately and as a mixture similar to natural spermaceti.
These studies are relevant to the provenance of "natural" or "green" cetyl laurate now appearing in high-value cosmetics and topical pharmaceutical products, but do not constitute evidence for any health benefit.
Cetyl laurate is almost exclusively associated with the integumentary system in both its historical and contemporary uses. Its primary verified roles are:
According to the INCI function database, cetyl laurate's listed functions are: emollient (softens and smoothes the skin), skin conditioning (maintains skin in good condition), and viscosity controlling (increases or decreases the viscosity of cosmetics).
Because lauric acid — released upon hydrolysis of cetyl laurate — is a natural constituent of human sebum and has demonstrated activity against skin-resident bacteria, cetyl laurate is sometimes positioned in the context of skin microbiome health. Free fatty acids and antimicrobial peptides are responsible for at least part of the self-antimicrobial disinfecting activity of the skin surface against microbial colonisation; they are secreted from sebaceous glands as sebum triacylglycerides and subsequently released through hydrolysation by lipases of the commensal bacterial flora. However, whether cetyl laurate contributes meaningfully to this endogenous system via topical application has not been evaluated in human studies.
Cetyl laurate is incorporated into cosmetic formulations as a wax component. No specific concentration ranges for cetyl laurate as a pure single-ingredient compound have been reported in peer-reviewed clinical studies, because no such studies of cetyl laurate alone have been identified. The ingredient appears in finished cosmetic products (creams, lotions, hair conditioners, lip products) as a minor functional component. According to cosmetic ingredient databases, cetyl laurate is present in approximately 0.01% of cosmetic products currently on the market.
For the broader cetyl esters wax class (of which cetyl laurate is a component), the US Pharmacopeia/National Formulary provides a monograph. Cetyl Esters Wax is a mixture consisting primarily of esters of saturated fatty alcohols (C12 to C18) and saturated fatty acids (C12 to C20); it contains not less than 90.0% of total saturated fatty esters and not less than 10.0% of fatty esters with a carbon-chain length of carbon number 32, which consist chiefly of cetyl palmitate. No specific pharmaceutical dosage by weight has been defined for cetyl laurate individually in the reviewed pharmacopoeial documents.
In the process chemistry literature, cetyl laurate synthesis in an open-air reactor has been studied at 350 rpm and 60 °C with varying amounts of the biocatalyst Novozym® 435. These parameters are production process specifications and are not relevant to clinical dosing.
The safety of cetyl esters as a class has been evaluated by the Cosmetic Ingredient Review (CIR) Expert Panel, the US body that independently assesses the safety of cosmetic ingredients. The CIR Expert Panel assessed the safety of 237 alkyl esters for use in cosmetics; cetyl esters were reviewed in 1997, and the Panel concluded that cetyl esters is safe as used in cosmetics. This conclusion was incorporated into a broader amended assessment of alkyl esters. The CIR has concluded that many of the individual constituents that make up the alkyl esters — i.e., the alcohol and/or the acid — are safe as used in cosmetics.
The data available for alkyl esters, including single-dose and repeated-dose toxicity, toxicokinetics, reproductive and developmental toxicity, genotoxicity, carcinogenicity, dermal and ocular irritation, and sensitisation and photosensitisation studies, support the safety of this class of cosmetic ingredients.
Regulatory bodies, including the FDA, recognise synthetic cetyl esters as safe for cosmetic and pharmaceutical use under the National Formulary (NF) standards. Cetyl Esters Wax meets the monograph of the US Pharmacopeia and can be used in OTC products and topical pharmaceuticals.
The CIR assessment of the alkyl ester class, including cetyl esters, covered dermal and ocular irritation data and sensitisation studies and supported the safety profile of the class. The conclusion reached by the CIR panel was that cetyl esters is safe as used in cosmetics. No specific sensitisation rate data for cetyl laurate as an isolated compound have been published in peer-reviewed clinical studies.
The cetyl alcohol component of cetyl laurate is separately documented with respect to skin tolerability: cetyl alcohol is considered safe for cosmetic use, as affirmed by the CIR Expert Panel (reaffirmed in 2005 and supported in ongoing reviews), with a low hazard rating from EWG. It shows minimal irritation, sensitisation, or comedogenicity at typical concentrations (1–10%).
There is only a modest volume of research specifically on cetyl laurate as an individual compound. The EWG Skin Deep database, which compiles hazard data on cosmetic ingredients, notes the limited quantity of dedicated research on this specific ester. Safety conclusions for cetyl laurate are therefore largely extrapolated from: (1) the CIR assessment of cetyl esters as a class; (2) the individually documented safety profiles of cetyl alcohol and lauric acid; and (3) the extended history of human use of spermaceti-derived waxes in topical and pharmaceutical preparations without reports of systemic toxicity.
No specific drug interactions with cetyl laurate have been reported in the peer-reviewed literature. As a wax ester used in topical preparations, cetyl laurate does not interact systemically with pharmaceutical drugs under normal conditions of topical cosmetic use. In formulation, long-chain wax esters of this type are generally compatible with most cosmetic and pharmaceutical excipients; they are not known to be reactive with common co-ingredients under typical storage conditions.
Historically, cetyl laurate-containing waxes were obtained from sperm whales — a source that is now globally prohibited. The whales were saved from extinction with the ban on whale oil use in 1972, followed by the species gaining full protection from whaling in 1986. Cetyl esters derived from plant-based sources and synthetic waxes engineered to replicate the texture and performance of spermaceti now offer ethical and sustainable substitutes in cosmetics, lubricants, and other applications. Contemporary manufacturers producing cetyl laurate via plant-derived cetyl alcohol (from coconut or palm oil) and plant-derived lauric acid are required to disclose the origin — plant, animal, or synthetic — of their ingredients; this is required by EU CosIng regulations. Different manufacturing options based on substances of different origin exist, and the origin may have evolved since initial entry into the relevant INCI dictionary. Consumers and formulators should verify the origin declaration with suppliers where vegan or cruelty-free status is required.
Health conditions that Cetyl laurate may help support.
Body systems that Cetyl laurate may help support.
Go back